Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Levoin

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Beilstein Journal of Organic Chemistry|October 29, 2025
Research towards selective inhibition of the CLK3 kinaseVinay Kumar Singh, Frédéric Justaud, Dabbugoddu Brahmaiah, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profileOlivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, et al.
Bioorganic & Medicinal Chemistry|June 26, 2022
Discovery of potent dual ligands for dopamine D4 and σ1 receptorsNicolas Levoin, Appala Venkata Ramana Murthy, Vennu Narendar, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based seriesOlivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, et al.
Archiv Der Pharmazie|September 26, 2008
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonistsNicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligandsMickaël Jean, Jacques Renault, Nicolas Levoin, et al.
European Journal of Medicinal Chemistry|November 20, 2018
Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cellsAppala Venkata Ramana Murthy, Vennu Narendar, Nangunoori Sampath Kumar, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2016
Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonistsOlivier Labeeuw, Nicolas Levoin, Xavier Billot, et al.
Cell Death & Disease|October 23, 2022
MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathwaysShoji F Kenji, Keerthi Kurma, Brigitte Collet, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2021
Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chainsAppala Venkata Ramana Murthy, Vennu Narendar, Nangunoori Sampath Kumar, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Beilstein Journal of Organic Chemistry|October 29, 2025
Research towards selective inhibition of the CLK3 kinaseVinay Kumar Singh, Frédéric Justaud, Dabbugoddu Brahmaiah, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2013
Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profileOlivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, et al.
Bioorganic & Medicinal Chemistry|June 26, 2022
Discovery of potent dual ligands for dopamine D4 and σ1 receptorsNicolas Levoin, Appala Venkata Ramana Murthy, Vennu Narendar, et al.
Bioorganic & Medicinal Chemistry Letters|July 26, 2011
Novel and highly potent histamine H3 receptor ligands. Part 2: exploring the cyclohexylamine-based seriesOlivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, et al.
Archiv Der Pharmazie|September 26, 2008
Refined docking as a valuable tool for lead optimization: application to histamine H3 receptor antagonistsNicolas Levoin, Thierry Calmels, Olivia Poupardin-Olivier, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2010
Synthesis and evaluation of amides surrogates of dopamine D3 receptor ligandsMickaël Jean, Jacques Renault, Nicolas Levoin, et al.
European Journal of Medicinal Chemistry|November 20, 2018
Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cellsAppala Venkata Ramana Murthy, Vennu Narendar, Nangunoori Sampath Kumar, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2016
Synthesis and evaluation of a 2-benzothiazolylphenylmethyl ether class of histamine H4 receptor antagonistsOlivier Labeeuw, Nicolas Levoin, Xavier Billot, et al.
Cell Death & Disease|October 23, 2022
MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathwaysShoji F Kenji, Keerthi Kurma, Brigitte Collet, et al.
Bioorganic & Medicinal Chemistry Letters|October 3, 2021
Synthesis and biological studies of new piperidino-1,2,3-triazole hybrids with 3-aryl isoxazole side chainsAppala Venkata Ramana Murthy, Vennu Narendar, Nangunoori Sampath Kumar, et al.
Pageof 4